Investors can redeem the fund at any time. T+ 1 transaction of the Fund will be redeemed on the trading day. According to the net value at the close of redemption date, the share will be confirmed on the second trading day. After the share is confirmed, the funds will arrive in the account, and the arrival time is generally 1-3 working days (depending on the product).
：
Tian Hong Fund was established on June 5438+065438+1October 8, 2004. It is one of the national public offering fund management companies approved by China Securities Regulatory Commission.
In 20 13, Tian Hong Fund cooperated with Alipay to launch Yu 'ebao, and was the fund manager of Yu 'ebao.
As of June 30th, 20 19, the management scale of Tian Hong Fund's public assets was 1203942 billion yuan, which was in the leading position in the industry.
As of September 30th, 20 19, the scale of Yu 'ebao was 1054822 billion yuan, ranking the largest single fund in China.
Since its establishment, as of September 30th, 20 19, Public Offering of Fund, a subsidiary of Tian Hong Fund, has made a profit of RMB 2,092,438+billion for its customers. By 20 18, the number of users of Tian Hong Fund has exceeded 500 million, making it the largest Public Offering of Fund company in China.
By the end of the third quarter of 20 19, Tian Hong Fund * * * had managed and operated 55 Public Offering of Fund, covering secondary market stock investment, bond investment, cash management, derivatives investment, and equity, creditor's rights and other property rights investment.
Except for the new funds, the annual returns of seven active equity funds under Tian Hong Fund (which were not included in the statistics less than one year after their establishment) all exceeded 40% in 20 19 years.
Specifically, Tian Hong cultural emerging industries achieved a high rate of return of 87.84% in 20 19 years, ranking the top three among similar funds in 1428, which was 35.78% ahead of the average performance of similar funds in the same period 1.5 times.
Tian Hong followed closely, with a return of 7 1.28% in 20 19, ranking 102 among 3,407 similar funds, and also leading the average performance of similar funds by 32.00%/.2 times.
In 20 19, Tian Hong's medical and health mix and Tian Hongyun's life optimization achieved a yield of more than 50%, while Tian Hong's selected mix, Tian Hongyong's fixed value growth mix and Tian Hong's cycle strategy mix achieved a yield of more than 40% in 20 19.